The Department of Justice (DOJ) is reportedly very close to approving the mergers between CVS and Aetna and Cigna and Express Scripts.
Those familiar with the deals predict the DOJ’s formal antitrust approvals will come within the next several weeks.
Update on the CVS-Aetna Merger
Regulators reportedly have some concerns that the almost $70 billion deal between CVS and Aetna could reduce competition in regard to Medicare drug coverage. It looks like they’ll require CVS and Aetna to sell some of their assets from their Medicare Part D business.
WellCare Health Plans could be one buyer of these assets; however, details about sale of assets are still being discussed among CVS, Aetna, and the DOJ.
Update on the Cigna-Express Scripts Merger
The $54 billion deal between Cigna and Express Scripts could be approved with no requirement to sell assets.
Spokespeople from both Express Scripts and Cigna previously stated they were confident the merger would close by the end of 2018.